# FDA places clinical hold on Regenxbio’s Hunter syndrome gene therapy

https://mins.news/en/item/30678

- Reuters, 2026-08-24 14:50 UTC
- Health
- Original: https://www.reuters.com/business/healthcare-pharmaceuticals/fda-places-clinical-hold-regenxbios-gene-therapy-hunter-syndrome-2026-08-24/?link_source=ta_bluesky_link&taid=6a8c5a280602a6000171c537

> Regenxbio said the U.S. FDA placed its experimental gene therapy for a rare inherited disorder on clinical hold after spinal scans showed abnormalities in five participants. Its shares fell more than 24% in premarket trading.